Eiko Lifesciences Ltd - 540204 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed herewith the Compliance Certificate under Regulation 7 (3) of the SEBI (LODR) Regulations, 2015 for the year ended 31st March, 2023. Eiko Lifesciences Ltd - 540204 - Closure of Trading Window
Pursuant to the Internal Code of Conduct for Prevention of Insider Trading framed by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended), please note that the "Trading Window" for purchasing/ selling/ dealing in the shares of the Company shall remain closed effective from April 1, 2023 for designated person (and their immediate relatives) and will be re-opened 48 hours after announcement of the audited financial results of the Company for the Quarter and year ending March 31, 2023 to the Stock Exchange. Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Further to our letter dated March 17, 2022, we would like to inform that the Company has completed the acquisition of the following: 1. Acquisition of 5% stake of 'Vivacious Pharmatex Private Limited' ('VPPL') by way of transfer of shares from the existing shareholders cum Directors of the VPPL to Eiko LifeSciences Ltd. Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Acquisition
The Meeting of the Board of Directors of the Company held today i.e., on Friday, 17th March, 2023 at 2:00 P.M. the Board, inter-alia, considered and approved the following. 1. Considered, approved and signed the Memorandum of Understanding (MOU) cum Share Purchase Agreement dated 17th March, 2023 with 'Vivacious Pharmatex Private Limited' ('VPPL') 2. Acquisition of 5% stake of 'Vivacious Pharmatex Private Limited' ('VPPL') by way of transfer of shares from the existing shareholders cum Directors of the VPPL at a total consideration not exceeding Rs. 5.10 Lacs. Ref. Annexure A & B for details. Eiko Lifesciences Ltd - 540204 - Disclosure Of Voting Results Of Postal Ballot (Regulation 44(3) Of SEBI (LODR) Regulation, 2015)
This is further to our letter dated 01st February 2023 submitting the postal Ballot Notice for seeking approval of members of the Company by way of Ordinary Resolution for 1. Increase in Authorised Share Capital of the Company. 2. Alteration of the Capital Clause of Memorandum of Association of the Company. The resolution placed through the Postal Ballot was passed with the requisite majority. Further in terms of Section 108 of the Companies Act, 2013 and rules made thereunder, the resolutions is deemed to be passed on the last date of e-voting, i.e., on 04th March 2023 Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra (HUF) Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lenus Finvest Pvt Ltd Eiko Lifesciences Ltd - 540204 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF